Yahoo Web Search

Search results

  1. May 30, 2023 · Learn about the preoperative evaluation, intraoperative management, and postoperative care of patients with myotonic dystrophy, a group of multi-system diseases with muscle weakness and myotonia. Find out the risks, monitoring, and anesthetic agents to avoid or use for these patients.

  2. People also ask

  3. Myotonic dystrophy (DM) is a genetic disorder that affects CNS, cardiac, respiratory, gastrointestinal, endocrine, and muscular systems in ways that increase the risk of anesthesia. Anesthesia Guidelines for pre-operative, intra-operative and post-operative care of DM patients, summarized

    • 43KB
    • 1
  4. Risks of anesthesia in Myotonic Dystrophy are most significant in the post-anesthesia period, but can be controlled by appropriate management. • During anesthesia, risks stem from the multisystemic features of Myotonic Dystrophy.

    • 91KB
    • 9
  5. Mar 20, 2019 · Providing anesthesia to patients with myotonic dystrophy (DM) can be very challenging due to the multisystemic effects of the disease and extreme sensitivity of these patients to sedatives, opioids, and anesthetic agents.

    • Chanchal Mangla, Kimmy Bais, Joel Yarmush
    • 2019
  6. Anesthesia raises special risks to those living with myotonic dystrophy (DM), as the disease results in heightened sensitivity to sedatives and analgesics.

  7. Jul 15, 2017 · In myotonic dystrophy, the endocrine system (thyroid and adrenal hormones) may be affected. Measuring appropriate hormone levels may help determine the need for preoperative replacement therapy (i.e. corticosteroids or thyroid hormones).

  8. Feb 20, 2017 · Here we discuss the case of a patient with DM for labral hip repair and review the literature on the management and anesthetic concerns of DM. Go to: Following the application of standard ASA monitors, a combined spinal and epidural anesthetic technique was performed successfully.

  1. People also search for